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INTRODUCTION 
          Pterygium is one of the common ocular conditions found in middle 
aged and elderly individuals. It is a benign, degenerative and proliferative 
condition of conjunctiva and subconjunctival tissue, with potential to 
cause visual disturbances. It can be easily diagnosed and staged by 
clinical examination. The most important factor related to the 
development of pterygium is thought to be sunlight exposure. Other 
contributing factors include dry eyes, smoking, prolonged outdoor 
activities, low socioeconomic status and high altitude. Major 
complication is the obscuration of visual axis if it grows into the centre of 
the cornea. The development of irregular astigmatism due to flattening of 
the cornea in the horizontal meridian is another cause of decrease in 
vision. 
  Hundreds of years ago Hippocrates, Galen and Celsus recognised 
pterygium as a triangular growth of bulbar conjunctiva onto the cornea
1
. 
Pterygium was thought to be a degenerative condition of the conjunctiva 
which encroaches onto the cornea. The name is derived from the Greek 
word ‘pterygos’ which means ‘wing or feather’. It is named so due to its 
resemblance to an insect wing. They were traditionally grouped under 
degenerative diseases.  But they show tumor like features like the 
propensity to invade normal ocular structure, high recurrence rate after 
  
resection and coexistence with other premalignant lesions
2
. Therefore it is 
described as a proliferative condition in recent literature
3
. There is also a 
thought that it may be derived from preexisting pinguecula, which is a 
degenerative condition of the conjunctiva
4
 or from conjunctivochalasis 
which is a dry eye related condition
5
. 
Pterygium is one of the very commonly encountered ocular 
condition in our country, which belongs to the “pterygium belt”  
described by Cameron
6
. It amounts to significant visual morbidity of our 
population. Proper understanding of the epidemiology and risk factors of 
this condition is essential for planning appropriate measures to prevent its 
occurrence and thereby reducing the physical and financial burden to the 
society. 
Epidemiology 
Even though the pterygium has a worldwide distribution it is seen 
most commonly in tropical and subtropical areas with warm and dry 
climate 
6
.  Hot, dry, dusty, windy areas have higher prevalence. The 
approximate global prevalence of pterygium varied from 2.8 to 33% in 
various studies
7,8
. Prevalence drops in areas more than 37 degree of 
latitude
6
. The prevalence is found to be low (2%) in regions above 40 
degrees and is high in equatorial regions (22%)
9,10
.The prevalence of 
pterygium could not be detected accurately in previous studies since it 
  
has some geographical distribution and there are no exact population 
based studies.  In Indian studies prevalence was found to be 11.7 % in a 
study in Andrapradesh
11
 and 9.5 % in a study in Tamilnadu
12
. 
Risk factors  
Although the exact cause of the development of pterygium is not well 
understood the exposure to ultraviolet light seems to be the most accepted 
risk factor(5). Dry eyes may also contribute to the development. 
Age group 
Pterygium is common in elderly individuals. It affects the people of 
age group 20 and above
6
. It is seen that the prevalence increases with the 
increasing age. The cumulative effect of the risk factors is responsible for 
this. It is also noted that the prevalence of pterygium increases in the age 
group above 40 but the incidence is more in the age group 20-40. The 
exact reason for this is still not known. 
Sex 
There is no general sexual predilection in disease occurrence. Some 
studies showed male preponderance
1314
 but others showed female
15
. Male 
preponderance shown in most of the studies, might be due to the fact that 
males were involved in the outdoor work, more often than women
16
. 
  
Heredity 
Pterygium is inherited in a dominant fashion with low penetrance. 
The way an eye reacts to the environmental factors is what is getting 
transmitted (6). Few studies have shown that pterygium is associated with 
positive family history
17
. 
Ultraviolet light exposure 
The ultraviolet (UV) light is made of 3 types of rays; UV A (400-320 
nm) responsible for tanning, UV B (320-290 nm) responsible for sunburn 
and skin cancer and UV C (290-100 nm) which do not reach the earth 
surface. The depletion of ozone layer in the recent years has caused more 
amounts of UV rays to reach the earth, thereby increasing the incidence of 
pterygium.   Pterygium was seen to be more common in regions around the 
equator, between the latitude 37 degree north and south
6
. It was found to be 
seen more commonly in people working outdoors who were more exposed 
to UV light than who worked indoors
10
.  Also, the risk was increased 
among people working outdoors with highly reflectance surfaces. Fresh 
snow reflects maximum of the UV light followed by sand and concrete 
pavement
9
. 
The systemic associations of pterygium further pointed out UV 
light as the common risk factor. It was seen associated with basal cell 
carcinoma, xeroderma pigmentosa, porphyria cutanea tarda
18
, 
  
hyperkeratosis, cutaneous melanoma
19
. The patients with pterygium also 
had cataract which was also linked to UV light
20
. 
Occupation 
Some kind of occupations increases the risk of developing 
pterygium. The people with outdoor occupation and spending more time 
in sun had more risk. It was also found to be more in welders who were 
exposed to harmful UV rays 
21,22
 The prevalence also increased in saw 
mill workers, labourers, fishermen,  station hands and stockmen. 
Tear film abnormalities 
Association of pterygium with dry eye was also documented. Local 
drying due to tear film abnormalities or high humidity with constant wind 
was found to be the risk factors. It was also proposed that the ultraviolet 
light causes rapid evaporation of tear film and  tear film dysfunction 
causing dry eye 
23
. Drying of the medial third of the palpebral fissure 
occurred when there was constant wind which also accounted for the 
more common nasal pterygium. 
Few other studies compared the effect of mucin deficiencies in 
pterygium. They found that, there was marked decrease in tear film break 
up time (TBUT) in pterygium patients when compared to the controls 
24
.  
  
Smoking and alcohol intake 
Cigarette smoking and alcohol increases the risk of developing 
pterygium
25
. Smoking induces an inflammatory reaction in the cornea 
which might be the trigger. There are few other studies which show that 
the incidence of pterygium is less in smokers
26
. So smoking is not a well 
documented risk factor. 
Effect of high altitude  
The people living in high altitude develop pterygium more 
frequently than those at lower altitudes
27
. Several physiological and 
pathological changes occur in the eye at high altitude. The ultraviolet 
radiation exposure is also higher at higher altitude. The prevalence of dry 
eye is also more in high altitudes adding to the risk factors
28
.  
Socio economic status 
People of low socio economic status are more prone to develop 
pterygium, since they more often engage in outdoor works
29
. Lack of 
knowledge and availability of protective sunglasses and hats make them 
more vulnerable
11
. 
 
 
  
Lack of protective glasses 
The sun glasses, hats and proper sheltering prevent some amount of 
UV light from entering the eyes
15,30
. 
Bilateral involvement 
Pterygium is usually a bilateral condition. But it is seen that one 
eye follows the next (sequential bilaterality). Bilateral involvement was 
documented in one third of cases. It was also seen in few studies that the 
bilateral cases had more sun exposure in their early lives compared to the 
unilateral cases
31
. 
 
Figure 1: bilateral pterygium (nasal) 
Pinguecula 
It is well accepted that pinguecula and primary pterygium are 
related to one another. But pinguecula do not precede the recurrent 
pterygium. According to Zehender pterygium is the encroachment of 
pinguecula onto the cornea
1
. It is proposed that the degeneration causes 
  
the elastic tissue to undergo hypertrophy and hyperplasia and deposition 
of hyaline material which will causes changes in the limbus by elevating 
it and incite the formation of the pterygium. The histopathology of 
pterygium and pinguecula had so many similarities except for the corneal 
changes
4
. So it was thought to be a precursor of pterygium which 
develops when there is a break in the limbal barrier
4
. 
Relevant anatomy related to the pterygium 
Anatomically the structures involved in the formation of pterygium 
are conjunctiva, limbus and the cornea 
Conjunctiva 
 It is a mucous membrane of the eye which lines the anterior part of 
eyeball and inner aspect of the lids. It can be divided into the palpebral 
part and the bulbar part which are connected to each other by the cul de 
sac, the fornix. The layers of conjunctiva histologically are the 
epithelium, adenoid layer and the fibrous layer. It consists of the mucin 
glands and the accessory lacrimal glands which are the glands of Krause, 
Wolfring and the rudimentary accessory lacrimal glands.  
The tarsal conjunctiva is firmly adherent to the tarsus.  The bulbar 
conjunctiva is loosely attached to the underlying tenons capsule. At the 
surgical limbus it will fuse with the tenons layer and the underlying 
  
episcleral tissue. The substantia propria of the conjunctiva stops here and 
the epithelium continues as the epithelium of the cornea. The epithelium 
at the limbus will be several layers thick and irregularly arranged. The 
episcleral plexus of vessels are situated at the limbus.  The conjunctival 
stroma, the limbal stroma and the bowmans layer of the cornea are in the 
same plane. Conjunctival stroma consists of fibroblasts, blood vessels and 
inflammatory cells. 
Limbus 
Anatomically the transitional zone between cornea and the 
conjunctiva and sclera is the limbus. The area is bounded anteriorly by a 
line joining the termination of bowmans and descemets membrane. The 
posterior aspect is the line joining scleral spur to a point perpendicular to 
the surface of cornea. This zone has important functions. The basal cells 
of the epithelium in this zone are regarded as the stem cells and the 
vascular loops in its stroma provide nourishment to the avascular cornea.  
The loss of the limbal cells in conditions like aniridia, inflammations and 
injuries to the ocular surface like the chemical burns is responsible for the 
loss of renewable source of corneal epithelial cells. 
 
 
  
Limbal epithelium 
It is similar to the corneal epithelium except for the fact that it has 
more melanocytes and langerhan cells. The basal cells of limbal 
epithelium are much smaller and less columnar than corneal and they 
have firm adhesions to the underlying stroma with undulating extensions. 
They have more number of mitochondria.  They form the stem cells of 
the corneal epithelium. They have the property of unlimited self renewal. 
Only 5 to 15% of limbal cells are stem cells 
32
. They have a centripetal 
migration. 
Connective tissue of the limbus is loosely and irregularly arranged. 
Capillaries, venules and small arterioles are present in this layer. The 
corneal epithelium continues as the conjunctival epithelium. The 
epithelium at the limbus is thrown into folds which are arranged radially. 
These are known as the palisades of Vogt. These are the folds which will 
lodge the basal cells .The blood vessels, lymphatics and nerves are 
present in the connective tissue within the folds. The lamina propria of 
the conjunctiva and the tenons capsule is the continuation of the 
bowmans membrane. Descemets membrane terminates at the schwalbes 
line. Endothelium continues as the endothelium of the trabecular 
meshwork.  
  
Blood supply of limbus is by anterior conjunctival artery which is a 
branch of the anterior cilary artery. 
Cornea  
It is a transparent structure which forms the anterior 1/6
th
 of the 
outer fibrous coat of the eyeball. Surface is elliptical with horizontal 
diameter of 11- 12 mm and vertical diameter of 10-11mm
1
. Cornea has a 
refractive power of 1.376.  Thickness in the centre is 0.52 and the 
periphery is 0.67 mm. The radius of curvature of anterior surface of 
cornea is 7.7 mm and posterior surface is 6.9 mm and a refractive power 
of 43 dioptres
32
. 
Cornea is made up of 5 layers: Epithelium, Bowman’s membrane, 
Stroma or the substantia propria, Descemet’s membrane and the 
endothelium from anterior aspect to posterior.  
Cornea is an avascular structure and do not have any lymphatic 
drainage. Small loops from the anterior ciliary vessels invade 1mm of the 
periphery
32
. These are in the overlapping subconjunctival tissue. It is 
richly supplied by nerve from the long ciliary nerves which makes plexus 
within cornea. 
 
  
Corneal transparency 
The transparency of the cornea is due to the avascular nature of the 
cornea and the regular arrangements of the corneal lamellae as well as 
due to an efficient endothelial pump mechanism. 
Histology & Pathogenesis 
Histologically pterygium contains area of varying thickness of  
limbal epithelium and bulbar conjunctiva which is made up of 
amorphous, eosinophilic material with a granular appearance
23
. It is 
covered by conjunctival epithelium. The subepithelial tissue resembles an 
elastic tissue which is actually abnormal collagen fibres which take the 
appearance of a coiled and fibrillated pattern
32
. It is not true elastic tissue 
since it is not digested by elastase. It is the effect of elastoid and elastotic 
degeneration of the collagen and fibrovascular proliferation. There is an 
increase in the stromal fibroblasts and a minor aggregation of 
mucopolysaccharides and other proteinaceous substances. The epithelium 
over it can be either atrophic, hyperplastic or even normal
23
.  
It was noticed with ultrastructural studies that the elastotic material 
came from degenerated collagen, preexisting elastic fibres, abnormal 
fibroblast activity and abnormal ground substance
33
. Dermis of the skin in 
the sun exposed individuals showed similar histological features. 
  
Pathogenesis 
Pterygium is a fibro vascular lesion with cellular proliferation, 
tissue remodeling and neovascularisation. There are large numbers of 
theories explaining the pathogenesis of pterygium, but the exact etiology 
is yet to be finalized
23
. The most common one is of ultraviolet radiation 
which showed that the exposure to UV radiation produces reactive 
oxygen species which may trigger the development of pterygium. There 
occurs damage to the bowmans membrane and thickening and 
hyperplasia of the bulbar sub conjunctival connective tissue due to the 
effect of UV radiation. The defects at the level of Bowmans membrane 
will be seen as the first clinical change
23
. This damage will trigger the 
fibroblasts at the limbus for the repair process. The reparative process 
will cause the deposition of elastotic material. The head of the pterygia 
grows in a plane which is between the Bowmans membrane and the 
epithelium. There occur inflammatory reactions. The increased cellular 
activity will cause ingrowth of blood vessels. The lymphokines released 
by the lymphocytes promote angiogenesis.  
The notable feature of the pterygium is that there is vascularisation 
in the avascular cornea. Ashton and cook put forward 2 theories to 
explain the vascularisation
34
. One theory is that cornea produces some 
substance which will cause the limbal vessels to grow. Second theory is 
  
that normally vascularisation is prevented by some growth inhibiting 
substance or due to corneal compactness. A breech in any of the two will 
cause vascularisation.  
Fromer and Klintworth showed that there occurred the arrival of 
leucocytes, macrophages and polymorphs before the vascularisation 
showing inflammatory nature
35
. Associated edema decreases the 
compactness which will allow easy penetration by new vessels. There 
occurs epithelial hyperplasia and fibrovascular growth. The modified 
limbal cells migrate and enter cornea. 
The residual corneal scarring after removal is because of the fact 
that the bowmans layer is destroyed by the pterygia. Immunohistologic 
studies showed altered limbal epithelial stems cells at the leading edge. 
Injury or activation of these stems cells with irradiation caused initiation 
of pterygium.MMP released by the altered limbal stem cells, may cause 
tissue remodeling, dissolution of bowmans membrane which is associated 
with the progression of pterygia.  
Inflammation 
  All the cases of the pterygia presents with chronic inflammatory 
reaction. There is a difference in the  goblet cell density in the pterygium 
and the rest of the normal conjunctiva
36
. The pterygium epithelium 
  
expresses Intercellular Adhesion Molecule 1 (ICAM 1) and Human 
Leukocyte Antigen (HLA DR) molecules and mediate the inflammatory 
reaction. Both the epithelium and stroma show infiltration of CD 4 and 
CD8 lymphocytes and also immunoglobulins IgG and IgE
37
. This 
indicates that both humoral and cell mediated immunity may be 
responsible for the pterygium pathogenesis. 
It has also been described that UV radiation can cause mutation in 
tumor suppressor gene p 53 and cause uncontrolled cell proliferation
38
. 
There occurs cell proliferation and genomic instability due to  loss of its 
heterozygosity and resultant inactivation 
39
. 
There occurs an immune reaction to vascular endothelial growth 
factor whose expression is increased in the pterygium tissue and less in 
normal conjunctival tissue
40
. Pterygium angiogenesis factor was produced 
due to repeated irritation at limbus which caused the vessel ingrowth. 
Endothelial progenitor cells and substance P may also be involved in the 
pathogenesis
41
. 
  Recurrence is more common in young people with pterygium. 
Recurrent pterygium will have fibrovascular proliferation and no elastotic 
degeneration. 
  
Lee JK et al showed that endothelial progenitor cells, substance P, 
vascular endothelial growth factor and stem cell factor are involved in the 
pathogensis
41
. 
The body of the pterygium is not attached to the episclera but to the 
tenons capsule explaining its mobility over the sclera. At the limbus lack 
of tenons capsule makes it adherent to the episclera. So a probe cannot be 
passed underneath it at the neck. 
Pterygium and astigmatism 
Pterygium induces significant changes in the topography of the 
cornea. There will be flattening in the horizontal meridian. The 
astigmatism so induced most probably will be with the rule astigmatism
42
 
or oblique astigmatism. Astigmatism may be either due to the mechanical 
traction on the cornea or due to the pooling of tears on the advancing 
edge of the pterygium
43
. A significant correlation between the corneal 
astigmatism and the size of pterygium was found in a previous study
44
. 
They found out that if the growth exceeded more than 45 % of the radius 
a significant degree of astigmatism was induced
44
. The amount of 
astigmatism was found to be proportionate to the length, depth and width 
of the pterygium which determines the pulling force
45
. The accurate 
measurement of this astigmatism is possible with the help of 
videoeratography and not with routine refraction or keratometry 
46
. The 
  
astigmatism developed due to pterygium was significantly reduced after 
its excision
43,44
. 
Classification of pterygium 
Pterygium is a raised triangular shaped lesion of the cornea. Base is 
on the paralimbal conjunctiva, apex towards the centre of the cornea.  
Anatomically it can be divided into the following parts 
• Fuchs patches- gray patches seen near the head  
• Stockers line- iron deposits seen as a brownish line due to chronic 
pooling of the tears anterior to the cap. 
• Hood- non vascular fibrous portion of pterygium 
• Head- highly vascular and raised part of the apex 
• Body- elevated fleshy portion with congested tortuous vessels 
• Base- paralimbal conjunctiva 
• Superior edge- upper edge of  traingular flap 
• Inferior edge- lower edge of  triangular flap 
 
 
 
  
The severity of the pterygium is evaluated based on few observations 
which include the following 
1) Length of encroachment onto the cornea 
• Stage 0- pinguecula-posterior to the limbus 
• Stage I restricted to the limbus 
• Stage II marginally invade the cornea 
• Stage III between limbus and pupillary margin 
• Stage IV central to the pupillary margin 
 
 
 
Figure 2 :Stage 1 pterygium 
 
 
 
  
 
 
Figure 3: Stage 2 pterygium 
 
 
 
Figure 4: Stage 3 pterygium 
 
  
The more the pterygium enchroaches on the cornea the more will be 
the visual symptoms of the patients. It may be because of the induced 
astigmatism or corneal irregularities or the obscuration of the pupil.  
2) The base width of the pterygium- measured with calipers- also 
important indicator of the severity 
3) The translucency of the pterygium tissue- a grading system was 
developed by Tan and co workers
47
 
Increased fleshiness or thickeness of the pterygium causes loss of 
translucency 
• Grade I- atropic pterygium- episcleral vessels are clearly visible 
• Grade II intermediate- episcleral vesels are partly visible 
• Grade III- fleshy opaque- episcleral vessels are wholly obscured 
 
 
 
 
 
 
 
 
 
 
Figure 5 : Regressive / Atrophic pterygium 
  
 
 
Figure 6 : Intermediate pterygium 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: Fleshy Pterygium 
 
  
 
Clinical signs 
Pterygium is an abnormal fold of membrane in the interpalpebral area 
strongly attached to its apex and the neck. A probe cannot be passed 
behind the neck of the pterygium. There is found to be no malignant 
transformation even though it shows the features of malignancy like local 
invasion and recurrence. It can present as 
• Progressive- it will be thick and fleshy with a cap and marked 
vasuclarity. It will increase in size and reach the centre or even 
cross it. 
• Stationary pterygium is vascular but its head looks less vascular 
and it will have a stockers line due to pooling of tears.  
• Regressive- it will be thin, grey with poor vascularity and no cap. 
• Primary double- both nasal and temporal pterygium present 
• Recurrent with more width after the primary excision 
• Pseudo pterygium- adhesion of a fold of conjunctiva onto the 
cornea. 
• Malignant pterygium- recurrent pterygium with restriction of 
movement to the opposite side. 
 
  
Symptoms 
Small pterygium is usually asymptomatic. As they grow the 
patients can have dry eye symptoms like eye discomfort, foreign body 
sensation, congestion, irritation and tearing. The dry eye symptoms are 
due to the irregular wetting of the corneal surface. As it progresses it may 
be apparent to the naked eye and may cause a cosmetic blemish to the 
patient. Further growth causes disturbances in visual acuity either due to 
direct encroachment or due to the induced astigmatism. Patient can also 
develop binocular diplopia especially in recurrent pterygium when the 
horizontal movement is restricted due to traction.  
Differential diagnosis 
The pterygium is not usually confused with other diseases. Some 
pathology of the limbus and the peripheral cornea can be included as 
differentials of the pterygium. The conditions are pseudopterygium, 
pinguecula, limbal dermoid, phlyctenular kerato conjunctivitis,, 
lymphoma of the conjunctiva, squamous cell carcinoma of th elimbus, 
nodular episcleritis and bowens disease. 
Pseudo pterygium is a fibrovascular scar extending from the 
conjunctiva to the cornea. It can occur in any corneal zone. It is formed 
by limbal inflammations or peripheral corneal tear repair. It can occur in 
  
any age group. It is always stationary and a probe can be passed beneath 
the neck. The limbal inflammation can be caused by chemicals, burns, 
and microbiological or autoimmune insults.  
Pingeucula are small yellow raised nodules on the nasal side of the bulbar 
conjunctiva. Some authors consider them to be the precursor lesion of 
perygium. 
Limbal dermoid is a benign congenital lesion most frequently seen in the 
inferotemporal limbus. 
Phyctenular keratoconjunctivitis is an inflammatory condition triggered 
by microbial antigens. 
Lymphoma of the conjunctiva are salmon coloured patches seen in the 
superficial conjunctiva 
Squamous cell carcinoma of the limbus develop from the limbal stem 
cells and are most commonly seen in the nasal or the temporal limbus of 
elderly individuals. It may have a gelatinous velvet pappilliform 
appearance. 
Nodular episcleritis presents as a freely mobile hard and tender nodule 
localised to one area of conjunctiva.  
  
Bowens epithelioma is a carcinomatoid lesion at the limbus induced by 
solar radiation. It is seen as reddish vascularised plaque at limbus. 
MANAGEMENT 
The definitive treatment of pterygium is surgical excision. But if 
the condition is in early stages we can manage it conservatively with 
lubricating eye drops. We have to educate the patients about the risk 
factors and motivate them to wear protective eye wear and hats. Mild 
corticosteroid or nonsteroidal eye drops can be given for inflamed 
pterygium.  When the lesion grows we have to remove it surgically after 
explaining the patient about the surgery, its complications and the high 
risk of recurrence. 
When to treat? 
48
 
1. When there is any threat to the vision due to invasion of visual axis 
2. Astigmatism and diminished  vision 
3. Eye movements getting restricted 
4. Any features suggestive of dysplasia 
5. Rapid increase in size 
6. Cosmetic 
 
  
Medical management 
Topical medications 
1) Bevacizumab  
There is evidence that Vascular Endothelial Growth Factor (VEGF) 
was thought to have a role in pathogenesis of pterygia
49
. 
Bevacizumab may be administered as drops of concentration 25 
mg/ml 4 times daily for 3  weeks
50
. 
2) Cyclosporine A causes reduction in the cellular proliferation.  
0.05 % can be used which will prevent proliferation
51
 
3) Mitomycin C (MMC) 0.02 % prevent recurrences but not used due 
to its side effects. 
Subconjunctival medications 
 Mitomycin C, 5 fluorouracil (5FU), Duanorubicin, Bevacizumab, 
Traimcinolone and Tiamcinolone with 5 FU can be used. These all 
help in preventing the recurrences.  
Surgical management 
The first recorded pterygium surgery was done by Susrutha around 
1000 B C. From then many authors have described the procedure in detail 
  
with few modifications from the original procedure recommended by 
susrutha. 
Celsus of Rome passed a thread beneath the pterygium and lifted it 
from sclera and removed with the help of a scalpel. Scarpa in 1802 was 
the first one to perform a bare sclera technique 
The definitive management of pterygium is surgical excision, the 
main aim being restoring the normal smooth ocular surface. The 
pterygium is removed with the help of flat blade dissecting it towards 
limbus and cut at the base. The closure of the wound involves various 
methods.  
Mc Reynolds procedure The pterygium head is separated from the 
cornea and the tissue is redirected to the lower fornix. This technique has 
become outdated. 
Bare sclera technique the sclera bed is left bare without closing and 
allowed to epithelialise. The conjunctiva is either not sutured or secured 
with sclera with fine sutures. But this technique has a high recurrence rate 
ranging from 24 to 89 percent
52
. If the defect is very small, we can do 
simple closure. 
Conjunctival autograft technique introduced by Kenyon et al
53
 involves 
the placing the conjunctival flap obtained from the superior or 
  
superotemporal quadrant of the same or the fellow eye on the sclera bed 
and suturing. The recurrence rate ranges from 2 to 40 percent
54,55
. 
Modifications of the conjunctival autografts we developed to decrease the 
recurrence rate. They were  
• Conjunctival limbal autograft which is more effective in 
recurrent pterygia and is taken from within 2mm of the limbus.  
• Conjunctival rotation autograft which is done if we have sacrred 
superior conjunctiva or limited area of donor tissue as in double 
headed pterygium. The epithelium is dissected and the inner 
fibrovascular tissue is removed. The epithelial layer is repositioned 
after rotating it to 180 degrees. 
Intraoperative mitomycin which is an antimetabolite can be used to 
prevent recurrences. They are used in a concentration of 0.01 to 0.04%. 
They suppress the ocular fibroblastic activity. The complications rate will 
be high if we use post operative drops, so single intraoperative dose of 
short duration application is practiced
56
. 
Amniotic membrane grafting can also be done. The amniotic membrane 
is placed with basement membrane facing up and the stroma down. The 
antiscarring anti inflammatory and anti angiogenic property of the 
  
amniotic membrane is utilized
54
.  Studies shows recurrence rate of 2.6 to 
10.7 percent in primary pterygium and 37.5 percent in recurrent
57
.  
Fibrin glue used instead of sutures help us in conserving the time of the 
procedure,and also decrease the amount of postoperative 
inflammation
58,59
. 
Autologous cryoprecipitate glue 
The use of autologous cryoprecipitate glue to keep the conjunctival 
autograft instead of suturing has also been done
60
. This method will cause 
less discomfort to the patient in terms of post operative pain. This may be 
superior to the commercially available fibrin glue. 
Adjunctive therapies 
The pterygium is well known for its recurrences. Adjunctive treatment 
helped in decreasing the rate of recurrence of pterygium after surgical 
excision. 
Mitomycin C: It is an antibiotic- antimetabolite- antineoplastic agent 
which has the ability to inhibit fibroblasts. Rapidly dividing cells are the 
most sensitive to Mitomycin C.  MMC is used intraopertively as 
mentioned previously as well as given to patient postoperatively as 
  
topical drops as 0.2 mg/ml(0.02%) or 0.4 mg/ml(0.04%) drops. Long 
term use of the topical MMC eye drops can result in ocular toxicity
56
. 
Beta irradiation inhibits mitosis in dividing cells. It causes ionization 
changes. Fibroblasts and the tissues with neovascularisation are most 
succeptible to irradiation thus helping in reducing the recurrences. 
Irradiation with strontium/yttrium 90 beta irradiation upto a total dose of 
50 Gy divided in 4 fractions one week apart. Now it is not used due to the 
side effects that it can cause like sclera necrosis and melt, cataract 
formation, and endophthalmitis. 
Complications of pterygium surgery
32
 
Perforation of globe, thinning of cornea or sclera, intraoperative bleeding, 
muscle damage can occur intraoperatively. 
Early postoperative complication includes persistent epithelial defect, 
corneal thinning, tear film abnormalities, loss of graft. 
Late complication includes recurrences, necrosis of cornea and sclera, 
endophthalmitis, scleritis. The bare sclera technique has the highest rate 
of recurrence. 
 
 
  
 
Figure 8 : Nasal pterygium pre excision  
 
 
Figure 9 : Nasal pterygium post excision with conjunctival Autograft  
 
  
REVIEW OF LITERATURE 
Mackenzie et al (1992) in his case control study of 278 patients with 
primary pterygia found that those patients who were outdoor workers 
with high reflectance surface had higher risk of pterygium compared to 
those who worked indoor. Those people working on sands had 100 fold 
and those with concrete surfaces had 20 fold increase in the risk while 
compared to indoor matched controls
9
. People spending 5 years of their 
life at 30 degree or less of latitude had 40 times the risk compared to 
greater than 40. They also found that protective glasses or hats had a 
strong positive correlation. 
Moran et al (1984) in his study in rural Australia involving >64000 
aborigines and 40,000 non aborigines found that found a strong positive 
correlation (p<0.001) between pterygium occurrence and the climatic UV 
radiation
10
. 
Sekelj et al (2007) evaluated the role of ultraviolet light as a cause of 
recurrent and primary pterygium in patients who underwent conjunctival 
autograft. They were grouped as sun exposed and non exposed and 
followed up for 6-12 months. They concluded that UV light had an 
important role in the development of both primary and recurrent 
pterygium
61
. 
  
Karai et al (1984) evaluated 191 Japanese welders and found a strong 
positive correlation with the welding occupation and the duration of 
occupation as a welder(p=<0.05) 
21
. 
Ajayi et al (2012) did a descriptive studyon 405 welders who included 
both arc and gas welders. 50.1 % had pingueculae and 17.5 % had 
pterygium which was a significant number and concluded that these were 
the common eye disorders among welders
22
. 
Shrestha S et al(2014) studied the prevalence of pterygium in high 
altitude and found that the prevalence was significantly increased in 
higher than in lower altitudes
27
. Several physiological and pathological 
changes occurs in the eye at high altitude. The ultraviolet radiation 
exposure is also higher at higher altitude.  
Gupta et al (2008) showed that the prevalence of dry eye is more in high 
altitudes than in lower
28
. 
In the study conducted by Veena M S et al (2013) on 300 eyes, the 
maximum number of pterygium patients belonged to the age group of 20-
60 years
62
. They could not find any difference in the incidence of 
pterygium in males and females. 
 
  
Pandey et al(1983)  conducted a study in Agra on 1400 eyes of patients 
along with 200 control eyes to assess the relationship between pterygia 
and lacrimation with the help of conventional schirmer’s test
63
. They 
came to a conclusion that the tear production in patients with pterygia 
was less (average <11 mm) compared to the controls. 
M M Balogun et al (2005) in his study concluded that the tear film break 
up time of <15 seconds was significantly associated with pterygium than 
controls. People with pterygium had unstable tear film
24
. 
Saw S M et al stated that cigarette smoking and alcohol increases the risk 
of developing pterygium
25
. 
Song et al (2016) in his cross sectional study concluded that smokers had 
less chance of developing pterygium than non smokers
26
. 
Booth (1985) in his study on 100 patients admitted for pterygium 
excision found that 38% had family history of pterygia compared to 12 % 
of controls
64
. 
Reisman D et al showed that UV radiation can cause mutation in tumor 
suppressor gene p 53 and cause uncontrolled cell proliferation
38
. causes 
loss of its heterozygosity and its inactivation which will cause cell 
proliferation and genomic instability
39
. 
  
Lee et al (2017) showed that the socio economic status of the people was 
an independent risk factor in the development of the pterygium when 
other factors were matched. People who were agriculture 
workers (16.52 ± 1.51%) or fishery workers had maximum incidence 
and the professionals (0.66 ± 0.22%)had the least29. 
Safi et al (2016) did a prospective study on 70 eyes with primary pterygia 
undergoing excision and post operatively the specimen was examined for 
histopathological analysis
65
. They showed that pterygium redness was 
significantly related to vascularity but not to the histopathological 
features. There was a relation of vascular density with the lesion 
dimension. 
Anguria et al (2013) studied 59 samples of pterygia for chronic 
inflammatory cells and damaged limbal cells and found that chronic 
inflammatory cells were present in all 59 samples
66
. The counts tend to 
increase with the increase in size of the pterygia. Most of the pterygia had 
mild inflammation mostly due to UV exposure. The pterygium 
occurrence has no association with damaged limbal stem cells.  
Nassar et al (2013) did histopathological evaluation(HPE) of 44 
pterygium specimens in patients who underwent surgery and showed that 
they had epithelial and stromal inflammations, vascular proliferation, 
solar elastosis and fibrosis. 96.2 % were positive for phosphor p 53 and 
  
96.3% ki-67 positive. These indicated high proliferative activity
67
. They 
did not find any significant difference in HPE of primary and recurrent 
pterygia. 
Raizada et al(1976) did histopathological examination on 10 pingeucula 
specimen and compared it with pterygium and found that it resembles late 
sclerotic or early fibrotic phase of pterygium and they concluded that 
pterygium develops from pinguecula
4
. 
Maheswari S(2007) assessed the corneal refractive changes induced by 
pterygium in 151 eyes with primary pterygia by the help of 
videokeratography
46
. She found that the topographic astigmatism 
increased with increase in the grade of the pterygium. There occurred a 
flattening of the horizontal meridian.The corneal astigmatism reduced 
from 4.40+3.64 dioptre to 1.55+/- 1.63 D following the surgery. 
Anguria et al (2014) evaluated 190 patients of pterygia who were 
followed up 6 months after surgery and compared the recurrence rate 
between young (50 years) and old( >50 years) patients
68
. It was found that 
75% of recurrent pterygium was in young individuals. Those patients had 
fast growing pterygia. 
Tan et al (1998) did a prospective trial in 123 primary and  34 recurrent 
pterygium eyes who underwent either bare sclera procedure or 
  
conjunctival autograft and found that 61%  of the bare sclera group and 
2%  of the conjunctival autograft group had recurrence
47
. They concluded 
that conjunctival autografting for both primary and recurrent pterygium 
reduced the risk of recurremce significantly. 
Tananuvat et al(2004) compared the amniotic membrane grafting with 
the conjunctival grafting for primary pterygium in 86 eyes and found that 
there was significantly high recurrence rate in the eyes that underwent 
amniotic membrane graft(40.9%) compared to the conjunctival autograft 
(4.76%) 
69
. 
Singh et al (2015) concluded in a study that administration of 
subconjunctival bevazizumab 1 week prior to the surgery as a single dose 
combined with conjunctival autograft decreases the recurrence rate by 
decreasing the vascularity of vessels
70
. 
 
 
 
 
 
 
  
AIMS AND OBJECTIVES 
 
AIM 
         To study and analyse the epidemiology of pterygium in tertiary care 
centre 
OBJECTIVES 
  To document the demography and clinical assessment of  
pterygium with regards to its size, stage and type. 
To analyse the collected data for identifying the risk factors and 
specific associations and correlations if any. 
 
 
 
 
 
 
  
DESIGN, METHODOLOGY AND TECHNIQUES 
Study design: 
Cross sectional observational study 
Sample size:  
104 patients 
Study duration:  
12 months, from June 2016 to May 2017 
Study Population:  
The patients with pterygium attending the outpatient clinic of 
Department of Ophthalmlology of Coimbatore Medical College Hospital 
who fulfilled the below mentioned selection criteria were included in the 
study 
 
 
 
 
 
  
Inclusion criteria 
1. People of age group >20 years 
2. True pterygium  
3. Patients with other comorbid conditions like diabetes and 
hypertension 
4. Patients with known dry eye syndrome 
 
Exclusion criteria 
1. Pediatric patients 
2. Patients with fundus pathology 
3. Glaucoma patients 
4. Pseudopterygium 
5. Injuries of eye 
6. Suspected ocular surface squamous neoplasia 
7. The patients who had asymmetrical pterygium in both eyes 
STUDY METHODOLOGY 
After selection of the cases, informed consent was obtained in their 
own language. Data collection was done using a structured questionnaire 
which comprises of socio-demographic characteristics including age, sex, 
occupation & detailed history. The exact hours of sun exposure per day 
  
and the years of sun exposure was noted as well as any other ocular or 
systemic co morbid conditions like diabetes and hyptertension. Patients 
were grouped into outdoor and indoor workers according to the nature of 
their occupation. They were categorized as rural and urban population 
depending on their hometown. Previous history of trauma, smoking 
habits and alcohol intake were also documented.  
For the purpose of analysis the patients coming from areas which 
were higher than 1000 meters from the sea level were considered as high 
and less than 1000 considered as low altitude. During symptoms 
assessment care was taken to find out if patient had any dry eye 
symptoms like irritation and burning sensation. 
A complete ocular examination was done and recording of the 
uncorrected and best corrected visual acuity along with the degree of 
astigmatism was done with the help of automated keratometry. 
Astigmatism was recorded as with the rule, against the rule or oblique 
astigmatism.  
For the purpose of analysis pterygium of one eye was considered in 
bilateral cases. The asymmetric bilateral cases were excluded from the 
study. Detailed slit lamp examination to find the stage and measurement 
of the pterygium was done. It was classified as stage I- restricted to 
  
limbus, stage 2- marginally invade the cornea, stage 3- between limbus 
and pupillary margin and stage 4- central to the papillary margin.  
Pterygium was classified as regressing, intermediate or fleshy 
pterygium according to Tan et al classification
47
 based on the visibility of 
episcleral vessels.  The position of pterygium was documented as nasal, 
temporal or double pterygium as well as whether the patient is having 
unilateral or bilateral pterygium. 
The tear film assessement was done with the help of Schirmers test 
and tear film break up time (TBUT). Schirmers strip was placed in the 
lower fornix at the junction of medial and lateral 2/3
rd
 and the 
measurement was taken after 5 minutes. TBUT was done under the 
guidance of slit lamp with the help of 2% flourescein strip to stain the tear 
film. The time taken for the first dark spot to appear is calculated in 
seconds. Both the values of Schirmers test and TBUT was grouped into 2 
for analysis. Those who had less than 10 seconds were considered as dry 
eye and more than 10 as normal value.  
 
 
 
  
 
Figure 10 : Examination of tear film break up test 
 
Figure 11: Schirmer’s test 
 
  
STATISTICAL ANALYSIS 
Data analysis was performed using statistical software package 
SPSS version 22.0. Both descriptive and inferential statistics were used. 
The data of categorical and ordinal variable were represented as 
frequencies and proportions. The data of continuous variable was 
represented as mean +/- standard deviation or mean based inter quartile 
range depending on the distribution of data. The comparison of 
continuous variable across different subgroups was done using one way 
analysis of variance (ANOVA). The comparison of categorical and 
ordinal variable across different subgroups were done using chi square 
test. Correlation analysis was done by estimating Pearson estimation co-
efficient. P value of less than 0.05 was considered significant.  
 
 
 
 
 
 
  
RESULTS AND OBSERVATIONS 
DEMOGRAPHIC CHARACTERISTICS OF PARTICIPANTS 
Demographic and clinical data of 104 patients are presented below 
AGE DISTRIBUTION 
Age of the patients ranged from 27 years to 78 years. The mean age 
of the study population is 51.5 years, the standard deviation being 13.5 
years.  
TABLE 01: Age distribution of study participants 
Age group Frequency Percentage 
26-35 15 14.42 
36-45 22 21.15 
46-55 28 26.92 
56-65 21 20.19 
>65 18 17.31 
Total 104 100.00 
 
  
 
 
CHART 01 
 
Majority of the patients belonged to the age group of 46- 55 (n=28, 
26.92%). None of the patients were less than 25 years. 
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GENDER DISTRIBUTION 
Females were more in the study group (n=70, 67%) 
TABLE 02- Gender distribution 
SEX FREQUENCY (n) PERCENTAGE (%) 
Male 34 33 
Female 70 67 
Total 104 100 
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OCCUPATION 
Majority of patients were engaged in outdoor works (n=82, 79%) 
TABLE 03 
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OCCUPATION FREQUENCY (n) PERCENTAGE (%) 
Indoor 22 21 
Outdoor 82 79 
Total 104 100 
  
  
ALTITUDE 
Most of the subjects were from low altitude areas (n=73, 70%) 
TABLE 04 
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70%
30%
FREQUENCY (n)
LOW (<1000 metres)
HIGH(>1000 metres)
ALTITUDE FREQUENCY (n) PERCENTAGE (%) 
Low (<1000 Metres) 73 70 
High(>1000 Metres) 31 30 
Total 
 
104 100 
  
 
RESIDENTIAL STATUS (URBAN/RURAL) 
TABLE 05 
 FREQUENCY PERCENATAGE  
Urban 31 29.8 
Rural 73 70.2 
Total  104 100 
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LATERALITY OF PTERYGIUM 
TABLE 06 
LATERALITY FREQUENCY PERCENTAGE 
Unilateral 54 51.9 
Bilateral 50 48.1 
TOTAL 104 100 
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TYPE OF PTERYIGUM 
TABLE 07 
Type of pterygium Frequency Percentage 
Regressive 45 43.27 
Intermediate 37 35.58 
Fleshy 22 21.15 
Total 104 100 
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STAGE OF PTERYGIUM 
TABLE 08 
STAGE FREQUENCY PERCENTAGE 
1 4 3.85 
2 37 35.58 
3 60 57.69 
4 3 2.88 
Total 104 100 
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SITE OF PTERYGIUM  
TABLE 09 
SITE OF PTERYGIUM FREQUENCY PERCENTAGE 
Nasal 94 90.4 
Temporal 6 5.8 
Double 4 3.8 
Total  104 100 
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SUN EXPOSURE 
Mean sun exposure hours-5.7 hours per day (SD.2.7hours) 
Mean years of sun exposure: 27.7 years (SD 11.7) 
TABLE 10 
  FREQUENCY PERCENTAGE 
Hours of sun 
exposure 
<=4 hours per day 23 22.1 
>4 hours per day 81 77.9 
Years of sun 
exposure 
<=20 years 38 36.5 
>20 years 66 63.5 
 
The patients engaged in indoor working had less than 4 hours of 
sun exposure per day and those working outdoor had 4- 9 hours of 
exposure per day. 
77.9 % (n=81) had significant sun exposure per day (>4 hours). 
63.5% (n=66) were exposed to long duration of sunlight for more 
than 20 years. 
 
  
SUN EXPOSURE 
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TABLE 11 
Daily hours of sun exposure  and type of pterygium 
Type of Pterygium Regressive Intermediate Fleshy 
Sun exposure in hours 
(Median – IQR) 
6 (6-7) 6 (2.5-7.5) 7 (6-8) 
 
Duration of sun exposure is not significantly different across types 
(Kruskal Wallis test, P = 0.087). But it is close to the significance. 
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TABLE 12 
Years of sun exposure and type of pterygium 
Type of Pterygium Regressive Intermediate Fleshy 
Sun exposure in 
years (Mean ± SD) 
24.38 ± 12.20 24.68 ± 8.94 34.77 ± 11.28** 
 
Years of sun exposure is significantly higher in the fleshy type in 
comparison to regressive (p<0.01) and intermediate types (P<0.01)  (One 
way ANOVA overall, P = 0.0008) 
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TABLE 13 
Cumulative hours of sun exposure and type of pterygium 
Type of Pterygium Regressive Intermediate Fleshy  
Sun exposure in 
years x hours (Mean 
± SD) 
148± 101 133± 93 227± 109** 
 
Cumulative sun exposure is significantly higher in the fleshy type in 
comparison to regressive (p<0.01) and intermediate types (P<0.01)  (One 
way ANOVA overall, P = 0.002) 
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COMORBID CONDITIONS & SMOKING 
TABLE 14 
 Present /Absent Frequency Percentage 
Diabetes 
 
Yes 28 26.9 
No 76 73.1 
Hypertension Yes 31 29.8 
No 73 70.2 
Either diabetes 
or hypertension 
Yes 45 43.3 
No 59 56.7 
Smoking Yes 24 23.1 
No 80 76.9 
 
 
 
 
 
  
TABLE 15 
Diabetic status and type of pterygium 
Type of 
Pterygium 
Regressive Intermediate Fleshy 
Proportion of 
diabetics 
12/45 8/37 8/22 
Proportion of the patients with diabetes as a comorbid risk factor was not 
significantly different across the various types (Chi square test for trend P 
= 0.52) 
TABLE 16 
Hypertensive status and type of Pterygium 
Type of 
Pterygium 
Regressive Intermediate Fleshy 
Proportion of 
Hypertensives 
15/45 9/37 7/22 
 
Proportion of the patients with Hypertension as a comorbid risk factor 
was not significantly different across the various types (Chi square test 
for trend P = 0.75) 
 
  
 
 
TABLE 17 
Smoking and type of Pterygium 
Type of 
Pterygium 
Regressive Intermediate Fleshy  
Proportion of 
patients who are 
smokers 
7/45 11/37 6/22 
 
Proportion of the patients who were smokers was not significantly 
different across the various types (Chi square test for trend P = 0.19) 
 
 
 
 
 
  
ASTIGMATISM 
TABLE 18 
ASTIGMATISM 
TYPE 
FREQUENCY PERCENTAGE 
No astigmatism 27 25.96 
With the rule 40 38.46 
Against the rule 11 10.58 
Oblique  26 25.00 
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TEAR FILM BREAK UP TIME  
TABLE 19 
TBUT in 
seconds 
Right Eye Left eye 
Frequency Percent Frequency Percent 
>10 85 81.73 85 81.73 
<10 19 18.27 19 18.27 
Total 104 100 104 100 
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SCHIRMERS TEST  
TABLE 20 
Schirmers test 
(mm) 
Right Eye Left eye 
Frequency Percent Frequency Percent 
>10 85 81.73 85 81.73 
<10 19 18.27 19 18.27 
Total 104 100 104 100 
 
CHART 16 
 
0
10
20
30
40
50
60
70
80
90
RIGHT EYE LEFT EYE
<10
>10
  
 
DRY EYE 
TABLE 21 
DRY EYE FREQUENCY PERCENTAGE 
No dry eye 85 81.73 
Dry eye 19 18.27 
TOTAL 104 100 
 
TABLE 22 
Dry eyes and type of Pterygium 
Type of Pterygium Regressive Intermediate Fleshy 
Proportion of 
patients with dry 
eyes 
7/45 10/37 2/22 
 
Proportion of the patients with dry eyes as a risk factor was not 
significantly different across the various types (Chi square test for trend P 
= 0.79) 
 
  
 
DISCUSSION 
Our study included 104 subjects who were diagnosed to have true 
pterygium in either or both of the eyes. 
 The mean age of the patients in our study was 51.5 years with a 
standard deviation of 13.5 years, which is comparable to previous studies. 
Youngest patient was 27 years and the oldest 78 years.  
In our study group most of the patients presented with cataract 
related diminished vision and pterygium was incidentally detected, which 
explains  the cause of slightly older age group of presentation in our 
study.  
15 patients (14.42%) were in the age group 26-35, 22 (21.15%) in 
the age group 36-45, 28(26.92%) in the age group 46-55, 21(20.19%) in 
the age group 56-65 and 18 (17.31%) in the age group >65 years, in our 
study. Majority of the patients presented in the age group of 45 to 55 
years (n=28, 26.92%) 
Females were predominant in our population (n=70, 67%).  Most 
of the previous studies have shown an increased incidence of pterygium 
in males, as men were commonly involved in outdoor works. 
16
. Our 
study population consisted of the people coming from low socioeconomic 
  
conditions were ladies involved in outdoor occupation. This may account 
for the increased number of female pterygium cases in our study. 
Our study had 79% of outdoor workers (n=82). The outdoor works 
included manual labourers, farmers, tea estate workers, concrete workers, 
coconut climbers and building painters. The association of UV light with 
occurrence of pterygium is well documented in previous studies
6,9,10
.  
Mean sun exposed hours was 5.7 hours per day with a standard 
deviation of 2.7 hours and mean year of sun exposure was 27.7 years with 
a standard deviation of 11.7 years. The average daily duration of sun 
exposure was not significantly different across types of pterygium 
(p=0.087). However the years of sun exposure (p=0.008) and cumulative 
hours of sun exposure (p=0.002) were significantly higher in the fleshy 
type.  
 Most of the patients in our study were from the rural area (n=74, 
70.2%). Rural area and low socioeconomic status are associated with 
more amount of outdoor work and more UV exposure. These people will 
have low level of education and may not be aware of the harmful effects 
of the UV light and thus don’t adopt protective measures such as hats and 
glasses
29
. 
  
On comparing the low and high altitude, it was seen that majority 
of patients came from the low altitude regions (n=73,70%) compared to 
high (n=31, 30%) .  The statistical significance between the effect of high 
altitude and pterygium was low in this study. This could be due to the 
small sample size of the patients coming from high altitude. However it is 
well documented that people living in high altitude has higher chance 
developing pterygium because of the higher UV light exposure along 
with dry eye
25,28
.  
Most of the patients presented with irritation and burning sensation 
(n=44, 42.3%) as their chief complaints. The rest presented with growth 
in the eye (n=22. 21.1%), gradual onset of blurring of vision (n=26,25%) 
or redness (n=12, 11.5%) as their presenting complaints.. 
We could not find any significant association between diabetes 
(p=0.52) and hypertension (p=0.75) with the type of the pterygium, in our 
study. No such correlation was documented in other studies also. The 
diabetic patients have more chance of developing tear film instability 
thereby making the eye more vulnerable to UV damage. 
54 cases (51.9%) cases in our study were unilateral and 50 (48.1%) 
were bilateral. Nasal pterygium (n=94, 90.4%) were more common than 
temporal (n=6, 5.8%)  or double pterygium (n=44, 3.8%). On comparing 
  
the type of the pterygium, regressive type was found to be more (n=45, 
43.27) than fleshy (n=22, 21.15) and intermediate (n=37, 35.58%) types. 
In our study 4 patients (3.85%) belonged to stage 1, 37 patients (35.68%) 
stage 2, 60 patients (57.68%) stage 3 and 3 patients (2.58%) stage 4. Most 
of the patients belonged to stage 2 and 3 which could be due to better 
awareness. 
Dry eye was found to be present in 19 patients (18.27%). Even though 
dry eye may be a risk factor for pterygium, statistical correlation could 
not be established in our study due to the small sample size (p=0.79). 
In the study group 50 patients (48.1%) had bilateral pterygium. 94 
patients (90.4%) had nasal pterygium and 4 patients (3.8%) had double 
pterygium. The sun rays going laterally through cornea, undergoing 
refraction and getting focused at the limbus on the nasal side can be an 
explanation for the nasal predominance.  Sunlight from lateral side go 
unobstructed through the cornea to medial side. The nose reduces the 
amount of sunlight falling on the lateral side. Even though it is unusual to 
find a temporal pterygium alone but it is not unlikely. 
Out of 104 patients 77 patients (74.04%) had astigmatism among which 
maximum were having with the rule astigmatism (n=40, 38.46%). This is 
in accordance with the other studies
46
. 
  
SUMMARY 
Our study entitiled ‘AN ANALYTICAL STUDY ON THE 
STUDY OF EPIDEMIOLOGY PTERYGIUM IN TERTIARY CARE 
CENTRE’ was a hospital based cross sectional study. 
The aim of the study was to study and analyse the epidemiology of 
pterygium in tertiary care centre 
The objective of the study was to document the demography and 
clinical assessment of pterygium with regards to its size, stage and type 
and to analyse the collected data for identifying the risk factors and 
specific associations and correlations if any. 
Middle aged to elderly people is more affected due to their 
prolonged exposure to inciting agents in the environment. Majority of the 
patients in our study were in the age group 45 to 55years. 
70 patients were females in our study but there is no significant 
gender predilection, if the environmental factors are the same. 
Mean sun exposed hours was 5.7 hours per day in our study. The 
average daily duration of sun exposure was not significantly different 
across types of pterygium. However the years of sun exposure and 
  
cumulative hours of sun exposure were significantly higher in the fleshy 
type.  
  74 patients were from the rural area and 73 patients were from low 
altitude regions in our study. Rural area and low socioeconomic status are 
associated with more amount of outdoor work and more UV exposure. 
These people will have low level of education and may not be aware of 
the harmful effects of the UV light and thus don’t adopt protective 
measures such as hats and glasses. 
In our study no significant association between high altitude and 
pterygium were found because of the low sample size. 
We could not find any significant association between diabetes and 
hypertension with the type of the pterygium, in our study. No such 
correlation was documented in other studies also. 
19 patients in our study group were diagnosed to have dry eye, 
with a break up time <10 seconds and schirmers <10 mm. Most of them 
were clinically asymptomatic. 
 
 
 
  
Most common clinical symptoms include irritation and foreign 
body sensation in eye, visual disturbances, redness and visible growth in 
eye. 
Visual disturbances in pterygium are due to obscuration of visual axis by 
the growth of pterygium, astigmatism and coexisting cataract. With the 
rule astigmatism are more commonly associated with pterygium. 
 
 
 
 
 
 
 
 
 
 
  
CONCLUSION 
Pterygium is one of the very commonly encountered ocular 
conditions in our country, especially affecting people of low 
socioeconomic strata.  It amounts to significant visual morbidity of our 
population. Proper understanding of the epidemiology and risk factors of 
this condition is essential for planning appropriate measures to prevent its 
occurrence and thereby reducing the physical and financial burden to the 
society.  
The role of prolonged sunlight and UV light exposure is a proven 
risk factor. Patient working outdoors should be counseled about the 
importance of wearing protective eye gears. 
It should be emphasized that such protective measures can not only 
delay the onset but also the progression of pterygium to some extent. 
Adequate management of asymptomatic dry eye is mandatory 
especially in patients working outdoors, as it can play a contributory role 
and hence the importance of dry eye evaluation in all cases of pterygium. 
Even though most of the study populations were from lower 
altitudes, the role of high altitude in the genesis of pterygium definitely 
needs to be considered. 
  
Though co morbid conditions like hypertension and diabetes do not 
play any role in the initiation and progression of pterygium, they can still 
contribute further to the visual morbidity. 
As pterygium is usually a bilateral disease and the development of 
one eye always precedes the other, educating the patient can delay the 
progression in the affected eye and also to reduce the risk of pterygium 
developing in the other eye to some extent. 
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DATA SHEET 
NAME: 
AGE:                   SEX:                            OCCUPTION: 
ADDRESS: 
Urban/rural 
 
HISTORY 
1. Presenting complaints 
 
2. Symptoms of dry eye 
 
3. Daily sun exposed hours 
 
4. h/o trauma 
 
5. Any ocular comorbidites 
 
6. Systemic comorbidities 
 
7. h/o smoking/alocohol 
 
8. previous h/o pterygium 
  
 
 
                                                             RE                         
LE 
1.Uncorrected visual acuity(UCVA)  : 
2.Refraction                                         : SPH 
                                                                CYL 
                                                                AXIS 
3.Best corrected visual acuity(BCVA): 
4.Tonometry-Non contact tonometry:               
5.Slit Lamp Examination                        
       Lids                                        : 
       Conjunctiva                          : 
       Cornea                                   : 
       Anterior chamber                 : 
       Iris                                           : 
       Pupil                                       : 
       Lens                                        : 
6. Tear film break up test   : 
7. Schirmmers test    : 
 
  
 
 
8.Fundus examination 
       Direct Ophthalmoscopy , +90 D and Indirect Ophthalmoscopy     
                       RIGHT EYE   LEFT EYE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
CONSENT  FORM 
         Here  by  I  volunteer  and  consent  to  participate  in  this  
study  “analytical study on epidemiology of pterygium in a tertiary 
care centre”. I  was  fully  explained  about  the  nature  of  this  
study  by  the  doctor;  knowing  which  I  Mr / Ms ……………….. 
fully  consent  to  volunteer  in  this  study. 
 
 
 
                                                                                 Signature  of  the  
volunteer 
Date: 
 Place:                                                                       Signature  of  the  
witness 
 
 
 
  
CONSENT FORM 
I  Dr. Swetha. K,  is  carrying  out  a  study  on  the  topic, 
“ANALYTICAL STUDY ON EPIDEMIOLOGY OF PTERYGIUM 
IN A TERTIARY CARE CENTRE”.    
My  research  project  guide  is  Dr.M.Hemanandini M.S.,D.O. 
My  research  project  is  being  carried  out  in  the  Department  of  
Ophthalmology, Coimbatore  Medical  College  Hospital, 
Coimbatore. 
        RESEARCH  BEING  DONE:  
ANALYTICAL STUDY ON EPIDEMIOLOGY OF PTERYGIUM 
IN A TERTIARY CARE CENTRE  
         PURPOSE  OF  RESEARCH 
 To document the demography and clinical assessment of  
pterygium with regards to its size, stage and type. 
 To analyse the collected data for identifying the risk factors and 
specific associations and correlations if any To  study  about  the  
following  factors  in  patients  with  pterygium, 
 
 
  
PROCEDURES  INVOLVED:  
                  Diagnosis of pterygium will be done clinically and a 
questionnaire will be administered to study about the demographic 
profile and the risk factors of pterygium. Complete visual 
examination will be done. The investigations like tear film analysis 
will be performed to identify the  risk  factors.  
               You, Shri./ Smt./ Kum. _________________________, 
aged ____ years, S/o / D/o / W/o ___________________________, 
residing  at ________________ 
_______________________________________ are requested  to  
be  a  participant  in  the  research  study  titled  ‘ANALYTICAL 
STUDY ON EPIDEMIOLOGY OF PTERYGIUM IN A 
TERTIARY CARE CENTRE’ in  Government  Medical College  
Hospital,  Coimbatore. You  satisfy  eligibility  criteria  as  per  the 
inclusion  criteria.  You  can  ask  any  questions  or  seek  any  
clarifications on  the  study  that  you  may  have  before  agreeing  to  
participate. 
 
 
 
  
DECLINE  FROM  PARTICIPATION 
You  are  hereby  made  aware  that  participation  in  this  study  is  
purely    voluntary  and  honorary  and  that  you  have  the  option  
and  the  right  to       decline   from   participation  in  the  study. 
         PRIVACY  AND  CONFIDENTIALITY 
You  are  hereby  assured  about  your  privacy.  Privacy  of  subject  
will  be respected  and  any  information  about  you  or  provided  by  
you  during  the     study  will  be  kept  strictly  confidential. 
AUTHORIZATION  TO  PUBLISH  RESULTS   
Results  of  the  study  may  be  published  for  scientific  purposes  
and/or    presented  to  scientific  groups, however  you  will  not  be  
identified;  neither     will   your   privacy   be  breached. 
 
 
 
 
 
 
  
STATEMENT  OF  CONSENT 
I, _____________________, do  hereby  volunteer  and  consent  to  
participate  in  this  study  being  conducted  by  Dr.Swetha.K. I  
have  read and  understood  the  consent  form / or  it  has  been  read  
and  explained  to me  in  my  own  language. The  study  has  been  
fully  explained  to  me, and whenever  I  ask  questions  at  any  
time. 
 
 
Signature / Left  Thumb  Impression  of  the  Volunteer          Date: 
 
Signature  and  Name  of  witness             Date: 
 
 
 
 
 
 
 
  
 
xg;g[jy; gotk; ; [ ; ;; [ ; ;; [ ; ;  
bgah;    : 
taJ    : 
ghypdk;    : 
Kfthp    :  
 muR nfhit kUj;Jtf; fy;Y}hpapy; fz; kUj;Jtj; Jiwapy; 
gl;l nkw;gog;g[ gapYk; khztp kU.!;ntjh.f;;;  mth;fs; nkw;bfhs;Sk; 
fz; Ma;tpy;/ fz; nehapd; (blhp$pak;) fhuz';fs; gw;wpa Ma;tpy; 
bra;Kiw kw;Wk; midj;J tpsf;f';fisa[k; nfl;Lf; bfhz;L/ vdJ 
re;njf';fis bjhpt[gLj;jpf; bfhz;nld; vd;gij bjhptpj;Jf; 
bfhs;fpnwd;.  
 ehd; ,e;j Ma;tpy; KG rk;kjj;JlDk;/ Ra rpe;jida[lDk; 
fye;J bfhs;s rk;kjpf;fpnwd;.  
 ,e;j Ma;tpy; vd;idg; gw;wpa midj;J tptu';fs; 
ghJfhf;fg;gLtJld;/ ,jd; Kot[fs; Ma;tpjHpy; btspaplg;gLtjpy; 
Ml;nrgid ,y;iy vd;gij bjhptpj;Jf; bfhs;fpnwd;. ve;j 
neuj;jpYk; ,e;j Ma;tpy; ,Ue;J ehd; tpyfpf; bfhs;s vdf;F chpik 
cz;L vd;gija[k; mwpntd;. 
,lk; : 
njjp :         ifbahg;gk; / 
nuif  
  
DRY  
RE LE TYPE STAGE NS/TEM RE LE RE LE RE LE
1 55 F ML OD RU LO GR 7 30 NIL NO 6\60 6\18 WTR BL RE 4 NS 15 16 21 20 NO SIMC SIMC
2 60 F HW ID RU HI IR 3 30 H NO 6\18 6\12 WTR UL IN 3 NS 9 8 7 9 YES SIMC SIMC
3 58 F ML OD RU LO DV 6 30 DH NO 6\36 6\24 WTR BL RE 3 NS 14 15 25 20 NO SIMC SIMC
4 50 F ML OD RU LO IR 9 27 DH NO 6\60 6\36 OBL BL FL 3 NS 16 17 16 18 NO SIMC SIMC
5 45 F TS OD RU HI GR 8 20 NIL NO 6\9 6\6 WTR BL RE 3 NS 16 16 18 17 NO EARLY EARLY
6 57 F TS OD RU HI DV 6 30 NIL NO 6\60 6\60 NONE BL RE 2 NS 18 18 19 19 NO SIMC SIMC
7 75 M FM OD RU LO DV 8 45 NIL YES 4\60 6\36 WTR BL RE 3 NS 17 17 17 20 NO SIMC IOL
8 35 M PO OD UR LO IR 5 16 NIL YES 6\6 6\6 NONE UL IN 2 NS 8 7 8 8 YES CLEAR CLEAR
9 27 M HW ID UR LO DV 2 8 H YES 6\12 6\12 OBL UL RE 3 NS 7 6 8 7 YES CLEAR CLEAR
10 48 M ML OD RU LO IR 8 30 NIL YES 6\12 6\9 AGR BL IN 3 TEM 20 21 22 20 NO EARLY EARLY
11 67 F ML OD RU LO GR 9 30 H NO 3\60 4\60 WTR BL IN 4 NS 7 8 6 7 YES SIMC SIMC
12 32 M CC OD RU LO DV 5 10 NIL YES 6\12 6\12 WTR BL IN 3 NS 9 9 8 8 YES CLEAR CLEAR
13 63 M PNR OD UR LO DV 8 20 D YES 6\60 6\36 AGR BL FL 2 NS 16 16 20 25 NO SIMC IOL
14 40 F HW ID RU LO RD 1 20 NIL NO 6\9 6\9 NONE BL IN 2 NS 17 17 22 16 NO CLEAR CLEAR
15 65 F ML OD RU HI RD 6 40 NIL NO 6\36 6\36 WTR UL RE 3 NS 16 16 25 18 NO SIMC IOL
16 29 F ML OD RU LO IR 7 10 NIL NO 6\12P 6\24 OBL UL RE 3 NS 18 18 16 19 NO CLEAR CLEAR
17 75 F ML OD UR LO IR 8 45 NIL NO 6\24 6\24 WTR UL FL 2 NS 20 20 18 20 NO IOL IOL
18 50 F HW ID UR LO DV 1 30 NIL NO 4\60 6\60 OBL UL IN 3 NS 23 20 19 18 NO SIMC SIMC
19 52 F ML OD RU LO IR 6 30 DH NO 6\36 6\24 WTR BL RE 3 NS 17 16 20 15 NO SIMC SIMC
20 45 F HW ID RU HI IR 2 20 NIL NO 6\36 6\24 OBL BL RE 3 NS 8 7 7 8 YES CLEAR CLEAR
21 33 F COM ID UR LO IR 2 6 NIL NO 6\6 6\6 NONE UL RE 2 NS 18 17 20 21 NO CLEAR CLEAR
22 38 F ML OD RU LO IR 8 10 NIL NO 6\12 6\9 WTR UL RE 3 NS 18 19 21 22 NO CLEAR CLEAR
23 63 M ML OD RU LO DV 7 40 NIL YES 1\60 6\60 NONE UL FL 3 NS 19 20 22 18 NO SIMC SIMC
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24 55 M ML OD RU HI DV 5 30 H NO 6\18 6\9 AGR BL FL 3 NS 15 15 18 20 NO IOL IOL
25 63 F HOT ID UR LO GR 0 40 H NO 6\18 6\36 NONE UL RE 3 NS 9 9 6 8 YES SIMC SIMC
26 63 F CW OD UR LO IR 6 30 H NO 6\9 6\12 WTR UL FL 2 NS 14 16 18 18 NO IOL IOL
27 70 F ML OD UR HI DV 6 50 NIL NO 6\36 1\60 AGR UL FL 2 NS 13 15 20 20 NO IOL SMC
28 70 F TS OD RU HI IR 3 30 H NO 6\18 6\12 OBL UL IN 3 NS 6 7 5 8 YES SIMC SIMC
29 42 F TS OD RU LO RD 7 20 NIL NO 6\18 6\18 OBL BL IN 3 NS 15 15 15 17 NO IOL IOL
30 65 F FM OD RU LO RD 7 21 NIL NO 6\36 6\60 NONE BL FL 2 NS 17 18 18 20 NO SIMC SIMC
31 40 F FM OD RU LO IR 6 38 H NO 6\6 6\6 NONE BL RE 3 NS 16 15 20 21 NO EARLY EARLY
32 50 F HW ID UR LO GR 0 33 DH NO 6\60 6\24 OBL UL IN 2 NS 9 8 7 7 YES SIMC IOL
33 37 M COM ID UR LO IR 1 10 NIL YES 6\9 6\12 NONE UL IN 3 NS 20 21 25 20 NO CLEAR CLEAR
34 40 F TS OD RU HI IR 7 21 DH NO 6\24 6\24 WTR UL RE 3 NS 16 16 16 22 NO IOL IOL
35 55 M ML OD RU LO GR 7 30 NIL NO 6\60 6\24 OBL BL RE 3 TEM 17 16 18 25 NO SIMC SIMC
36 62 F TS OD RU LO DV 8 39 NIL NO 6\60 6\60 WTR BL IN 3 NS 19 18 19 16 NO SIMC SIMC
37 40 M ML OD RU LO DV 8 22 DH NO 6\18 6\18 OBL UL RE 3 NS 15 16 20 18 NO CLEAR CLEAR
38 51 F ML OD RU LO IR 9 27 DH NO 6\36 6\36 OBL BL FL 3 NS 14 15 22 19 NO SIMC SIMC
39 43 F HW ID UR LO GR 1 20 NIL NO 6\12 6\36 WTR BL IN 2 BOTH 13 15 25 25 NO EARLY EARLY
40 55 F TS OD RU HI GR 8 30 NIL NO 6\60 2\60 WTR BL RE 3 NS 17 16 16 16 NO SIMC SIMC
41 76 M FM OD RU LO DV 7 50 NIL YES HM 6\60 NONE BL FL 3 NS 15 16 18 18 NO SIMC SIMC
42 37 M PO OD UR LO GR 5 16 NIL YES 6\6 6\6 NONE UL IN 3 NS 18 19 19 19 NO CLEAR CLEAR
43 27 M CW OD UR LO IR 7 8 NIL NO 6\6 6\6 NONE UL IN 2 NS 17 18 22 22 NO CLEAR CLEAR
44 55 M ML OD RU LO IR 8 30 NIL YES 6\36 6\60 AGR BL IN 2 NS 16 17 25 25 NO SIMC SIMC
45 67 F ML OD RU LO IR 9 48 H NO 3\60 4\60 WTR BL RE 3 NS 19 18 16 16 NO SIMC SIMC
46 37 M WL OD RU LO IR 6 14 NIL NO 6\12 6\12 WTR UL RE 3 NS 16 17 18 18 NO CLEAR CLEAR
 
  
47 68 M PNR OD UR HI DV 8 20 D YES 4\60 6\36 WTR BL IN 3 NS 8 7 6 7 YES SIMC SIMC
48 38 F ML OD RU LO GR 7 16 D NO 6\9 6\9 OBL BL IN 2 NS 15 15 21 20 NO CLEAR CLEAR
49 67 F ML OD RU LO RD 7 40 D NO 6\36 6\36 AGR UL IN 2 NS 13 13 17 18 NO SIMC IOL
50 28 F ML OD RU LO GR 8 10 NIL NO 6\12P 6\24 WTR BL RE 2 NS 11 11 16 17 NO CLEAR CLEAR
51 50 M ML OD UR LO IR 9 30 NIL NO 6\24 6\24 WTR UL RE 2 NS 18 18 20 21 NO SIMC SIMC
52 76 F CW OD UR LO IR 9 45 NIL NO 4\60 6\36 WTR BL RE 3 NS 16 16 25 21 NO SIMC IOL
53 56 F ML OD RU LO IR 6 30 NIL NO 6\12 6\9 NONE UL IN 1 NS 15 15 15 17 NO IOL IOL
54 49 F HW ID RU LO IR 2 20 NIL NO 6\12 6\24 NONE BL FL 2 NS 17 17 16 15 NO EARLY EARLY
55 30 F COM ID UR LO IR 2 6 NIL NO 6\6 6\6 NONE BL RE 3 NS 15 20 16 16 NO CLEAR CLEAR
56 35 F ML OD RU LO IR 8 10 NIL NO 6\9 6\9 WTR UL RE 3 NS 16 17 19 16 NO CLEAR CLEAR
57 64 M ML OD RU LO DV 7 40 NIL NO 6\60 6\12 OBL UL IN 2 NS 17 19 18 19 NO SIMC IOL
58 50 M FM OD RU HI DV 5 30 H YES 6\18 6\9 OBL BL RE 3 NS 15 14 17 18 NO IOL IOL
59 57 F HOT ID UR HI GR 0 28 H NO 6\18 6\36 NONE UL RE 3 NS 7 9 8 7 YES SIMC SIMC
60 58 M CW OD UR LO IR 6 30 H NO 6\9 6\12 WTR UL RE 2 NS 20 21 16 22 NO IOL IOL
61 73 F ML OD RU LO DV 6 44 D NO 6\60 HM NONE BL FL 1 NS 17 16 18 25 NO SIMC SMC
62 65 F TS OD RU HI GR 9 35 NIL NO 6\24 6\36 OBL BL IN 3 NS 19 20 19 16 NO IOL SIMC
63 39 F TS OD RU HI RD 6 15 NIL NO 6\12 6\12 WTR UL RE 3 NS 20 20 20 18 NO CLEAR CLEAR
64 41 F FM OD RU LO RD 7 18 NIL NO 6\18 6\24 OBL UL RE 3 NS 20 20 22 19 NO CLEAR CLEAR
65 47 F FM OD RU HI DV 7 20 DH NO 6\18 1/2\60 AGR UL RE 4 NS 16 16 25 25 NO SIMC SIMC
66 55 F HW ID UR LO GR 0 30 NIL NO 6\6 6\6 NONE BL IN 2 NS 17 17 16 16 NO CLEAR CLEAR
67 30 F COM ID UR LO IR 1 7 D NO 6\12 6\9 WTR UL RE 2 NS 19 19 20 25 NO CLEAR CLEAR
68 35 F TS OD RU HI IR 6 15 NIL NO 6\12 6\12 OBL UL RE 2 NS 9 8 8 6 YES CLEAR CLEAR
69 67 M BUS ID UR LO DV 0 29 NIL YES 3\60 6\60 WTR UL FL 3 NS 14 15 20 20 NO SIMC SIMC
 
  
70 57 M FM OD RU LO IR 7 33 NIL YES 6\60 6\36 NONE BL FL 1 TEM 15 14 18 20 NO SIMC SIMC
71 63 F TS OD UR HI IR 6 30 H NO 6\9 6\12 WTR UL IN 1 NS 14 15 30 25 NO SIMC SIMC
72 44 F ML OD RU LO IR 5 20 D NO 6\18 6\18 AGR UL RE 3 NS 6 5 7 8 YES CLEAR CLEAR
73 49 F TS OD RU HI DV 6 27 DH NO 6\12 6\24 OBL BL RE 3 NS 18 17 20 18 NO IOL IOL
74 46 F ML OD RU LO RD 8 22 D NO 6\9 6\9 NONE UL IN 3 NS 17 15 21 20 NO CLEAR CLEAR
75 70 F HW ID RU LO RD 0 50 NIL NO 1\60 4\60 OBL UL FL 2 NS 15 16 22 20 NO SIMC SIMC
76 45 M FM OD RU LO GR 6 20 NIL NO 6\12 6\24 NONE UL RE 3 NS 16 14 18 20 NO EARLY EARLY
77 33 F HW ID UR HI GR 0 8 D NO 6\12 6\9 OBL BL IN 2 NS 14 13 19 20 NO CLEAR CLEAR
78 55 F FM OD RU LO IR 6 30 D NO 6\18 6\24 NONE UL FL 2 TEM 9 8 7 8 YES SIMC SIMC
80 47 F TS OD RU LO IR 6 25 NIL NO 6\18 6\12 WTR UL IN 3 NS 7 7 7 8 YES SIMC SIMC
81 51 M TS OD RU LO GR 7 30 NIL YES 6\60 6\18 OBL BL RE 3 NS 18 17 21 20 NO SIMC SIMC
82 78 F ML OD RU LO IR 8 50 NIL NO 6\18 6\12 WTR UL FL 2 NS 17 15 22 20 NO IOL IOL
83 57 M ML OD RU LO IR 6 35 DH NO 6\36 6\24 OBL BL IN 2 NS 15 15 18 16 NO IOL IOL
84 46 F ML OD RU LO DV 9 27 DH NO 6\60 6\36 OBL BL FL 3 NS 15 14 18 18 NO SIMC SIMC
85 42 F HW ID UR LO GR 0 21 NIL NO 6\9 6\6 WTR BL IN 2 BOTH 14 13 14 19 NO EARLY EARLY
86 54 F TS OD RU HI DV 6 30 NIL NO 6\60 6\36 WTR BL IN 3 NS 16 15 16 20 NO SIMC SIMC
87 73 M ML OD RU LO DV 8 50 NIL NO HM 5\60 NONE BL FL 2 NS 9 9 9 8 YES SIMC SIMC
88 38 M WL OD UR LO IR 5 16 NIL YES 6\6 6\6 NONE UL IN 3 NS 17 16 19 0 NO CLEAR CLEAR
89 29 M CC OD UR LO GR 6 6 NIL NO 6\12 6\12 WTR UL RE 3 NS 7 9 7 8 YES CLEAR CLEAR
90 52 M FM OD RU LO IR 8 30 NIL YES 6\60 6\12 AGR BL IN 3 TEM 14 10 14 14 NO SIMC IOL
91 70 F ML OD RU LO DV 8 45 H NO 3\60 4\60 OBL UL FL 3 NS 15 14 20 20 NO SIMC SIMC
92 36 M FM OD RU HI GR 9 18 D YES 6\12 6\9 NONE UL IN 2 NS 11 12 12 12 NO CLEAR CLEAR
93 64 M ML OD UR LO DV 8 20 D YES 6\60 6\36 AGR BL FL 3 NS 17 17 18 18 NO SIMC SIMC
 
  
94 34 F TS OD RU HI IR 6 15 H YES 6\9 6\9 NONE UL IN 2 NS 7 8 7 8 YES CLEAR CLEAR
95 66 F ML OD RU LO RD 7 40 DH NO 6\36 6\36 WTR UL RE 2 NS 16 15 15 18 NO SIMC IOL
96 29 F ML OD RU HI RD 6 8 D NO 6\12P 6\24 WTR UL RE 3 NS 17 18 25 16 NO CLEAR CLEAR
97 53 F ML OD UR LO IR 7 30 NIL NO 6\24 6\24 WTR UL RE 2 BOTH 16 15 16 20 NO SIMC SIMC
98 75 M HW ID UR LO RD 0 50 D NO CFCF 6\18 AGR UL RE 2 NS 18 18 20 20 NO SIMC IOL
99 52 F ML OD RU LO IR 6 30 NIL NO 6\60 6\60 WTR UL IN 3 NS 20 20 20 26 NO SIMC SIMC
100 40 F HW ID RU LO IR 2 20 H NO 6\6 6\6 NONE UL IN 2 TEM 23 23 26 25 NO CLEAR CLEAR
101 55 F ML OD RU LO GR 7 30 NIL YES 6\60 6\18 OBL BL RE 3 NS 17 17 23 20 NO SIMC SIMC
102 60 F HW ID RU LO IR 3 30 H NO 6\18 6\12 WTR UL IN 3 NS 8 9 8 6 YES SIMC SIMC
103 58 M ML OD RU LO DV 6 30 DH YES 6\36 6\24 WTR BL RE 3 NS 19 19 25 25 NO SIMC SIMC
104 50 F ML OD RU LO IR 9 27 DH NO 6\60 6\36 OBL BL FL 2 NS 16 16 20 20 NO SIMC SIMC
105 45 F TS OD RU LO GR 6 20 NIL YES 6\9 6\6 WTR BL RE 3 BOTH 20 20 20 18 NO EARLY EARLY
 
 
 
  
KEY TO MASTER CHART 
F- Female 
M- Male 
OCC- Occupation 
ML- Manual Labourer 
HW- House Wife 
TS- Tea Estate 
FM- farmer 
PO- Police 
CC- coconut climber 
PNR- painter 
COM- Company 
HOT- hotel 
CW- Concrete worker 
BUS- business 
OD- outdoor 
ID- indoor 
RU- rural 
UR- urban 
LO- low alititude 
HI- high altitude 
UCVA – Uncorrected Visual Acuity 
CO- Complaints 
GR- growth 
IR- irritation 
DV- defective vision 
RD- redness 
SH- sun exposed hours 
SY- sun exposed years 
D/H- Diabetes/ hypertension 
SM-Smoking 
ASTIG – Astigmatism  
WTR- with the rule 
AGR- against the rule 
OBL- oblique 
UL- unilateral 
BL- bilateral 
FL- fleshy 
IN- intermediate 
RE- regressing 
NS- nasal 
TEM- temporal 
TBUT- tear film break up time 
 
 
